Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemiaYIN XU; DOLAN, Michelle M; NGUYEN, Phuong L et al.American journal of clinical pathology. 2003, Vol 120, Num 5, pp 778-784, issn 0002-9173, 7 p.Article

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyTALPAZ, Moshe; SILVER, Richard T; HOCHHAUS, Andreas et al.Blood. 2002, Vol 99, Num 6, pp 1928-1937, issn 0006-4971Article

Flow cytometric analysis of aneuploidy and S-phase fraction in chronic myeloid leukemia patients: role in early detection of accelerated phaseTRIPATHI, Anil K; CHATURVEDI, Rupesh; AHMAD, Rizwan et al.Leukemia research. 2003, Vol 27, Num 10, pp 899-902, issn 0145-2126, 4 p.Article

Sweet's syndrome and accelerated phase of chronic myelogenous leukemiaFERNANDEZ-JIMENEZ, M. C; HERRAEZ, R; OJEDA, E et al.Annals of hematology (Print). 2000, Vol 79, Num 10, pp 585-587, issn 0939-5555Article

Chediak-higashi syndrome : Report of a case with uncommon presentation and review literatureKANJANAPONGKUL, Somjai.Chot Mai Het Thang Phaet. 2006, Vol 89, Num 4, pp 541-544, issn 0125-2208, 4 p.Article

Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia : Comparison with historic experienceKANTARJIAN, Hagop; TALPAZ, Moshe; DE LIMA, Marcos et al.Cancer. 2005, Vol 103, Num 10, pp 2099-2108, issn 0008-543X, 10 p.Article

Clinical course of thrombocytopenia in patients treated with imatinib mesylate for accelerated phase chronic myelogenous leukemiaVAN DEVENTER, Hendrik W; HALL, Melissa D; ORLOWSKI, Robert Z et al.American journal of hematology. 2002, Vol 71, Num 3, pp 184-190, issn 0361-8609, 7 p.Article

The Role of Resting Duration in the Kinematic Pattern of Two Consecutive Bench Press Sets to Failure in Elite Sprint KayakersGARCIA-LOPEZ, D; HERRERO, J. A; ABADIA, O et al.International journal of sports medicine. 2008, Vol 29, Num 9, pp 764-769, issn 0172-4622, 6 p.Article

Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course: A study of 59 patientsSHIN, Hyung Ju C; CARAWAY, Nancy P; KATZ, Ruth L et al.Cancer. 2003, Vol 99, Num 5, pp 293-300, issn 0008-543X, 8 p.Article

Staging of chronic myeloid leukemia in the imatinib era : An evaluation of the world health organization proposalCORTES, Jorge E; TALPAZ, Moshe; O'BRIEN, Susan et al.Cancer. 2006, Vol 106, Num 6, pp 1306-1315, issn 0008-543X, 10 p.Article

Accelerated phase at initial presentation: An uncommon occurrence in Chédiak-Higashi syndromeAHLUWALIA, J; PATTARI, S; TREHAN, A et al.Pediatric hematology and oncology. 2003, Vol 20, Num 7, pp 563-567, issn 0888-0018, 5 p.Article

A constitutive scaling law for shear rupture that is inherently scale-dependent, and physical scaling of nucleation time to critical pointOHNAKA, Mitiyasu.Pure and Applied Geophysics. 2004, Vol 161, Num 9-10, pp 1915-1929, issn 0033-4553, 15 p.Article

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysisKHOURY, H. J; KUKREJA, M; GALE, R. P et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 6, pp 810-816, issn 0268-3369, 7 p.Article

The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg : the GIMEMA CML Working Party experience after a 7-year follow-upPALANDRI, Francesca; CASTAGNETTI, Fausto; LEVATO, Luciano et al.Haematologica (Roma). 2009, Vol 94, Num 2, pp 205-212, issn 0390-6078, 8 p.Article

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemiaREA, D; ETIENNE, G; ROUSSELOT, P et al.Leukemia. 2012, Vol 26, Num 10, pp 2254-2259, issn 0887-6924, 6 p.Article

Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaOKI, Yasuhiro; KANTARJIAN, Hagop M; GHARIBYAN, Vazganush et al.Cancer. 2007, Vol 109, Num 5, pp 899-906, issn 0008-543X, 8 p.Article

Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapyBORTHAKUR, Gautam; KANTARJIAN, Hagop; DALEY, George et al.Cancer. 2006, Vol 106, Num 2, pp 346-352, issn 0008-543X, 7 p.Article